XCancer

Phase I Clinical Trial of the Safety, Pharmacokinetics, Biodistribution and Dosimetry of 68Ga-LNC1007 Injection in Adult Healthy Volunteers and Solid Tumor Patients

Description:

This study is a single-arm, single-center trial aimed at evaluating the safety, pharmacokinetics, biodistribution and dosimetry of 68Ga-LNC1007 Injection in adult healthy volunteers and solid tumor patients.

Sponsor:

Yantai LNC Biotechnology Singapore PTE LTD

Phase:

Phase 1

Contacts:

Professor Khong Pek-Lan

65 65167408

Government Study Link:

NCT06463782 - Click here to see study on

ClinicalTrials.gov